Nocardiosis (Pulmonary and Cutaneous Infections) (Nocardia species)

Overview

Plain-Language Overview

Nocardiosis is an infection caused by bacteria called Nocardia species that mainly affects the lungs and sometimes the skin. It often occurs in people with weakened immune systems, but can also affect healthy individuals. The infection can cause symptoms like cough, fever, and skin sores or abscesses. It spreads through inhaling dust or through cuts in the skin. If untreated, it can lead to serious complications by spreading to other parts of the body such as the brain. Diagnosis usually requires special tests to identify the bacteria. Treatment involves long courses of antibiotics to clear the infection.

Clinical Definition

Nocardiosis is a bacterial infection caused by aerobic, filamentous, weakly acid-fast Nocardia species, primarily affecting the pulmonary and cutaneous systems. It typically arises from inhalation of environmental Nocardia spores or direct inoculation into the skin, leading to localized or disseminated infection. The disease is characterized by granulomatous inflammation and abscess formation, often in immunocompromised hosts such as those with HIV/AIDS, organ transplants, or chronic corticosteroid use. Pulmonary nocardiosis presents with cough, fever, and lung nodules or cavitary lesions on imaging, while cutaneous nocardiosis manifests as cellulitis, abscesses, or mycetoma. Dissemination to the central nervous system or other organs can occur, increasing morbidity. Diagnosis relies on microbiological identification of Nocardia from clinical specimens. Early recognition and prolonged antimicrobial therapy are critical due to the organism’s resistance patterns and potential for relapse.

Inciting Event

Inhalation of soil-contaminated dust containing Nocardia species initiates pulmonary infection.
Direct inoculation through skin trauma causes cutaneous nocardiosis.
Exposure to environmental sources such as gardening or farming is common antecedent.
Use of immunosuppressive medications triggers reactivation or increased susceptibility.

Latency Period

Symptom onset typically occurs days to weeks after exposure or inoculation.
Pulmonary nocardiosis may have a subacute to chronic course with gradual symptom development.
Cutaneous infections often develop within 1 to 2 weeks post-trauma.
Disseminated disease latency varies depending on immune status and infection site.

Diagnostic Delay

Nonspecific symptoms and radiographic findings often mimic tuberculosis or malignancy.
Slow growth of Nocardia in culture delays microbiological diagnosis.
Lack of clinical suspicion in immunocompetent patients leads to missed diagnosis.
Misidentification as contaminants or other bacteria on initial cultures causes delay.

Clinical Presentation

Signs & Symptoms

Chronic cough with sputum production and hemoptysis in pulmonary nocardiosis
Fever, night sweats, and weight loss as systemic symptoms
Painful, erythematous nodules or abscesses in cutaneous infections
Neurological deficits such as headache, focal weakness, or seizures if CNS is involved
Fatigue and malaise commonly accompany disseminated disease

History of Present Illness

Pulmonary nocardiosis presents with chronic cough, fever, and weight loss over weeks.
Cutaneous nocardiosis manifests as painful nodules, abscesses, or ulcers at inoculation sites.
Progressive respiratory symptoms with hemoptysis and pleuritic chest pain may occur.
Disseminated infection can cause neurological symptoms if the brain is involved.

Past Medical History

History of immunosuppressive therapy or organ transplantation is common.
Chronic lung diseases such as COPD or bronchiectasis increase risk.
Previous trauma or skin wounds may precede cutaneous infection.
HIV infection or other causes of cellular immunodeficiency are relevant.

Family History

[]

Physical Exam Findings

Fever and tachypnea in pulmonary nocardiosis
Localized erythema, swelling, and tenderness in cutaneous nocardiosis
Lymphadenopathy near cutaneous lesions
Crackles or decreased breath sounds on lung auscultation
Abscess formation or draining sinus tracts in skin infections

Diagnostic Workup

Diagnostic Criteria

Diagnosis of nocardiosis requires isolation and identification of Nocardia species from clinical specimens such as sputum, pus, or tissue biopsy. Microscopic examination reveals branching, filamentous, weakly acid-fast gram-positive rods. Imaging studies like chest X-ray or CT can show characteristic pulmonary nodules or cavitary lesions. Definitive diagnosis depends on culture growth on selective media, which may take several days. Molecular methods such as PCR can aid in rapid identification and species differentiation.

Pathophysiology

Key Mechanisms

Inhalation or direct inoculation of Nocardia species leads to localized infection.
Intracellular survival within macrophages due to the organism's ability to resist oxidative killing.
Granulomatous inflammation and abscess formation cause tissue destruction in lungs and skin.
Dissemination via hematogenous spread can lead to systemic involvement, especially in immunocompromised hosts.

Involvement	Details
Organs	Lungs are the primary site of infection in pulmonary nocardiosis, presenting with nodules, cavitary lesions, or infiltrates.
	Skin is frequently involved in cutaneous nocardiosis, manifesting as cellulitis, abscesses, or ulcers.
	Brain involvement occurs in disseminated nocardiosis, leading to abscess formation and neurological deficits.
Tissues	Pulmonary tissue is commonly involved in nocardiosis, showing abscess formation and granulomatous inflammation.
	Cutaneous tissue is affected in localized infections, often with ulceration and abscesses.
	Central nervous system tissue may be involved in disseminated disease causing brain abscesses.
Cells	Neutrophils are critical for phagocytosis and killing of Nocardia species during infection.
	Macrophages participate in intracellular killing and antigen presentation in nocardiosis.
	T lymphocytes mediate adaptive immune responses essential for controlling disseminated nocardiosis.
Chemical Mediators	Interferon-gamma enhances macrophage activation and intracellular killing of Nocardia.
	Tumor necrosis factor-alpha (TNF-α) promotes granuloma formation and containment of infection.
	Reactive oxygen species (ROS) produced by phagocytes contribute to bacterial killing.

Treatments

Pharmacological Treatments

Trimethoprim-sulfamethoxazole (TMP-SMX)
- Mechanism:
  - Inhibits bacterial folate synthesis by blocking dihydropteroate synthase and dihydrofolate reductase.
- Side effects:
  - Rash
  - Hyperkalemia
  - Bone marrow suppression
  - Renal toxicity
- Clinical role:
  - First-line
Imipenem
- Mechanism:
  - Binds penicillin-binding proteins to inhibit bacterial cell wall synthesis.
- Side effects:
  - Seizures
  - Allergic reactions
  - Gastrointestinal upset
- Clinical role:
  - Second-line
Amikacin
- Mechanism:
  - Binds 30S ribosomal subunit to inhibit bacterial protein synthesis.
- Side effects:
  - Nephrotoxicity
  - Ototoxicity
  - Neuromuscular blockade
- Clinical role:
  - Adjunctive
Linezolid
- Mechanism:
  - Inhibits bacterial protein synthesis by binding 50S ribosomal subunit.
- Side effects:
  - Myelosuppression
  - Peripheral neuropathy
  - Serotonin syndrome
- Clinical role:
  - Second-line

Non-pharmacological Treatments

Surgical drainage or debridement of abscesses or necrotic tissue in cutaneous or pulmonary nocardiosis.
Supportive respiratory care including oxygen therapy for pulmonary involvement.
Immunosuppression reduction when feasible to enhance host defense.

Prevention

Pharmacological Prevention

Trimethoprim-sulfamethoxazole prophylaxis in high-risk immunocompromised patients
Alternative prophylaxis with minocycline or imipenem in sulfa-allergic patients
No vaccine available for Nocardia species

Non-pharmacological Prevention

Avoidance of soil exposure and activities involving decaying organic matter in immunocompromised hosts
Use of protective clothing and gloves when handling soil or plant material
Prompt wound care and hygiene to prevent cutaneous inoculation
Regular monitoring and early evaluation of symptoms in immunosuppressed patients

Outcome & Complications

Complications

Disseminated nocardiosis involving brain, skin, and other organs
Pulmonary abscess formation and cavitation
Central nervous system abscesses causing neurological deficits
Chronic cutaneous ulcers and sinus tract formation
Respiratory failure from extensive lung involvement

Short-term Sequelae	Long-term Sequelae
Persistent fever and systemic inflammatory response Localized abscess formation requiring drainage Respiratory distress due to lung involvement Neurological symptoms from early CNS abscesses Skin ulceration and secondary bacterial superinfection	Pulmonary fibrosis and chronic lung damage after infection resolution Neurological deficits from healed brain abscesses Chronic draining sinus tracts in cutaneous nocardiosis Recurrence of infection due to incomplete treatment Functional impairment from organ damage

Differential Diagnoses

Nocardiosis (Pulmonary and Cutaneous Infections) (Nocardia species) versus Tuberculosis

Nocardiosis (Pulmonary and Cutaneous Infections) (Nocardia species)	Tuberculosis
Nodular or cavitary infiltrates often in lower lobes with filamentous branching on microscopy	Upper lobe cavitary lesions with well-formed granulomas
Weakly acid-fast, branching filamentous gram-positive bacteria	Acid-fast bacilli that are strictly aerobic mycobacteria
Requires sulfonamides such as trimethoprim-sulfamethoxazole	Responds to standard antitubercular therapy including isoniazid and rifampin

Nocardiosis (Pulmonary and Cutaneous Infections) (Nocardia species) versus Actinomycosis

Nocardiosis (Pulmonary and Cutaneous Infections) (Nocardia species)	Actinomycosis
Granulomatous inflammation with weakly acid-fast branching filaments	Sulfur granules with dense fibrotic tissue and branching filamentous bacteria
Weakly acid-fast, aerobic gram-positive branching rods	Non–acid-fast, anaerobic gram-positive branching rods
Associated with soil exposure and immunocompromised states	Associated with poor dental hygiene or oral trauma

Nocardiosis (Pulmonary and Cutaneous Infections) (Nocardia species) versus Pulmonary Aspergillosis

Nocardiosis (Pulmonary and Cutaneous Infections) (Nocardia species)	Pulmonary Aspergillosis
Filamentous, branching, weakly acid-fast bacteria	Septate hyphae with acute angle branching on microscopy
Occurs in patients with impaired cell-mediated immunity or chronic lung disease	Common in neutropenic or severely immunocompromised patients
Responds to sulfonamides such as trimethoprim-sulfamethoxazole	Responds to voriconazole or amphotericin B

Nocardiosis (Pulmonary and Cutaneous Infections) (Nocardia species) versus Cutaneous Sporotrichosis

Nocardiosis (Pulmonary and Cutaneous Infections) (Nocardia species)	Cutaneous Sporotrichosis
Associated with soil exposure and traumatic inoculation	Associated with rose thorn injuries or plant material
Granulomatous inflammation with filamentous branching bacteria	Granulomatous inflammation with cigar-shaped yeast forms
Responds to sulfonamides such as trimethoprim-sulfamethoxazole	Responds to itraconazole

Nocardiosis (Pulmonary and Cutaneous Infections) (Nocardia species) versus Staphylococcal Skin Infection

Nocardiosis (Pulmonary and Cutaneous Infections) (Nocardia species)	Staphylococcal Skin Infection
Gram-positive branching filamentous rods, weakly acid-fast	Gram-positive cocci in clusters, catalase and coagulase positive
Subacute to chronic course with indolent abscesses and sinus tracts	Rapid onset with purulent abscess formation
Requires sulfonamides such as trimethoprim-sulfamethoxazole	Responds to beta-lactam antibiotics or vancomycin